Inhibition of apelin/APJ axis enhances the potential of dendritic cell-based vaccination to modulate TH1 and TH2 cell-related immune responses in an animal model of metastatic breast cancer
- 12 March 2022
- journal article
- research article
- Published by Elsevier in Advances in Medical Sciences
- Vol. 67 (1) , 170-178
Abstract
No abstract availableKeywords
Funding Information
- Rafsanjan University of Medical Sciences (97166)
This publication has 36 references indexed in Scilit:
- Apelin-13 induces MCF-7 cell proliferation and invasion via phosphorylation of ERK1/2International Journal of Molecular Medicine, 2015
- Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancerHuman Pathology, 2015
- Apelin promotes lymphangiogenesis and lymph node metastasisOncotarget, 2014
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironmentCurrent Opinion in Immunology, 2013
- Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: Association with tumor-derived growth factorsExperimental and Molecular Pathology, 2007
- The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity during immunological responsesJournal of Neuroimmunology, 2003
- Cyclic AMP Activates p38 Mitogen-Activated Protein Kinase in Th2 Cells: Phosphorylation of GATA-3 and Stimulation of Th2 Cytokine Gene ExpressionThe Journal of Immunology, 2000
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.Journal of Experimental Medicine, 1992